Market closed
Xencor/$XNCR
Xencor shares are trading lower after the company reported a Q1 loss that was wider than expected.
15 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Xencor
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Ticker
$XNCR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
250
ISIN
US98401F1057
Website
Xencor Metrics
BasicAdvanced
$593M
-
-$3.05
0.99
-
Price and volume
Market cap
$593M
Beta
0.99
52-week high
$26.42
52-week low
$7.16
Average daily volume
1M
Financial strength
Current ratio
5.894
Quick ratio
5.737
Long term debt to equity
25.946
Total debt to equity
34.726
Interest coverage (TTM)
-4.62%
Management effectiveness
Return on assets (TTM)
-11.42%
Return on equity (TTM)
-34.05%
Valuation
Price to revenue (TTM)
4.462
Price to book
0.93
Price to tangible book (TTM)
0.95
Price to free cash flow (TTM)
-3.311
Growth
Revenue change (TTM)
-25.88%
Earnings per share change (TTM)
27.24%
3-year revenue growth (CAGR)
-26.97%
3-year earnings per share growth (CAGR)
19.66%
What the Analysts think about Xencor
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Xencor stock.
Xencor Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Xencor Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Xencor News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Xencor stock?
Xencor (XNCR) has a market cap of $593M as of May 10, 2025.
What is the P/E ratio for Xencor stock?
The price to earnings (P/E) ratio for Xencor (XNCR) stock is 0 as of May 10, 2025.
Does Xencor stock pay dividends?
No, Xencor (XNCR) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Xencor dividend payment date?
Xencor (XNCR) stock does not pay dividends to its shareholders.
What is the beta indicator for Xencor?
Xencor (XNCR) has a beta rating of 0.99. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.